The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis. Møller M, Søndergaard HB, Koch-Henriksen N, Sorensen PS, Sellebjerg F, Oturai AB Acta Neurol Scand. 2013 May 14. PMID: 23668375. Abstract CommentRecommendBookmarkWatch